Dana- Farber Cancer Institute — Boston, Massachusetts

Dana- Farber Cancer Institute is a clinical research site located in Boston, Massachusetts, United States 02215-5450.

Crixeo Health Trust Score: 50/100 (POOR). This profile has not yet been claimed by the site owner.

Dana- Farber Cancer Institute has participated in 2 clinical trials.

Therapeutic areas: Multiple Myeloma, Pediatric Brain Tumor, Diffuse Intrinsic Pontine Glioma.

Sponsors: Nerviano Medical Sciences, Alaunos Therapeutics.

Sponsor Feasibility Report

Trust Score: 50/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana- Farber Cancer Institute?

Dana- Farber Cancer Institute has a Crixeo Trust Score of 50/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana- Farber Cancer Institute conducted?

Dana- Farber Cancer Institute has 2 clinical trials on record. Their work covers Multiple Myeloma, Pediatric Brain Tumor, Diffuse Intrinsic Pontine Glioma.

Is Dana- Farber Cancer Institute accredited by Crixeo Health?

Dana- Farber Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana- Farber Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.